These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20805139)

  • 21. Ocular amyloidosis: clinical points learned from one case.
    Bene C; Kranias G
    Ann Ophthalmol; 1990 Mar; 22(3):101-2. PubMed ID: 2331125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for floaters.
    Mura M; Engelbrecht LA; de Smet MD; Papadaki TG; van den Berg TJ; Tan HS
    Ophthalmology; 2011 Sep; 118(9):1894-1894.e1. PubMed ID: 21889665
    [No Abstract]   [Full Text] [Related]  

  • 23. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy.
    Sandgren O; Kjellgren D; Suhr OB
    Acta Ophthalmol; 2008 Aug; 86(5):520-4. PubMed ID: 18435819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical characterization of vitreous amyloid formed after liver transplantation.
    Liepnieks JJ; Phan AD; Wise RJ; Hrisomalos FN; Benson MD
    Amyloid; 2016 Jun; 23(2):136-7. PubMed ID: 27043487
    [No Abstract]   [Full Text] [Related]  

  • 25. Bilateral amyloidosis of the vitreous body: report of a case without systemic of familial involvement.
    Ferry AP; Lieberman TW
    Arch Ophthalmol; 1976 Jun; 94(6):982-91. PubMed ID: 59590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vitreous amyloidosis. Apropos of 2 cases with an ultrastructure study].
    Trepsat C; Hullo A; Durand L; Bouvier R
    Bull Soc Ophtalmol Fr; 1984; 84(6-7):853-6. PubMed ID: 6534628
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary non familial amyloidosis of the vitreous and subretinal amyloid bodies.
    Rosenthal G; Walter P; Bartz-Schmidt KU; Heimann K
    Int Ophthalmol; 1999; 23(1):1-2. PubMed ID: 11008891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous opacities and retinal vascular abnormalities in Gaucher disease.
    Shrier EM; Barr CC; Grabowski GA
    Arch Ophthalmol; 2004 Sep; 122(9):1395-8. PubMed ID: 15364726
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary nonfamilial amyloidosis of the vitreous. A light microscopic and ultrastructural study.
    Biswas J; Badrinath SS; Rao NA
    Retina; 1992; 12(3):251-3. PubMed ID: 1410835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of vitreous opacities in a case of familial amyloidotic polyneuropathy by vitreous surgery.
    Giora T; Gad K; Mordechai P
    Metab Pediatr Ophthalmol; 1981; 5(2):105-8. PubMed ID: 6270477
    [No Abstract]   [Full Text] [Related]  

  • 31. Twenty-five gauge vitrectomy for vitreous opacities secondary to ocular toxoplasmosis.
    Eugênio Faria E Arantes T; Garcia C; Morais F; Muccioli C
    Acta Ophthalmol; 2011 Sep; 89(6):e538-40. PubMed ID: 20698830
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional and anatomical results of vitreopapillary traction after vitrectomy.
    Meyer CH; Schmidt JC; Mennel S; Kroll P
    Acta Ophthalmol Scand; 2007 Mar; 85(2):221-2. PubMed ID: 17305740
    [No Abstract]   [Full Text] [Related]  

  • 33. The management of wound-related complications in pars plana vitrectomy.
    Kreiger AE
    Trans Am Ophthalmol Soc; 1994; 92():307-20; discussion 320-4. PubMed ID: 7886870
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ocular lesions in primary familial amyloidosis (a syndrome associating opacitieis of the vitreous body, vascular lesions of the retina and an amyloid neuropathy)].
    Franceschetti AT; Rabinowicz T
    J Genet Hum; 1969 Oct; 17(3):349-66. PubMed ID: 4319009
    [No Abstract]   [Full Text] [Related]  

  • 35. Incomplete posterior vitreoschisis and vitreomacular traction.
    Carpineto P; Mastropasqua L
    Am J Ophthalmol; 2005 Oct; 140(4):765-6; author reply 766. PubMed ID: 16226545
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diseases of the vitreo-macular interface].
    Koerner F; Garweg J
    Klin Monbl Augenheilkd; 1999 May; 214(5):305-10. PubMed ID: 10420374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macular OCT changes after vitrectomy.
    Khan K; Jayaswal R; Madhusudhan S; Gibran SK
    Ophthalmology; 2007 Oct; 114(10):1955. PubMed ID: 17908604
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation.
    Kawaji T; Ando Y; Hara R; Tanihara H
    Ophthalmology; 2010 Mar; 117(3):552-5. PubMed ID: 20045573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome.
    Witkin AJ; Patron ME; Castro LC; Reichel E; Rogers AH; Baumal CR; Duker JS
    Ophthalmic Surg Lasers Imaging; 2010; 41(4):425-31. PubMed ID: 20608611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary nonfamilial ocular amyloidosis.
    Knapp CM; Sarodia U; Brown L; Bibby K
    Eye (Lond); 2003 Mar; 17(2):252-4. PubMed ID: 12640419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.